期刊文献+

冠状动脉微栓塞后MCP-1变化的实验研究 被引量:4

Changes of monocyte chemotactic protein-1 after coronary microembolization
下载PDF
导出
摘要 目的经导管建立急性冠状动脉微栓塞模型,检测微栓塞后单核细胞趋化因子-1 (monocyte chemotactic protein-1,MCP-1)的变化情况。方法12只小型猪,通过导管方法建立急性冠脉微栓塞模型,观察急性期(微栓塞前、微栓塞后2 h、6 h)及慢性期(微栓塞前、微栓塞后1周)血清中MCP-1浓度变化,RT-PCR观察心肌组织中MCP-1及粒细胞变化。结果MCP-1随时间变化逐渐增加,MCP-1在2 h有明显增加,与基础相比P<0.05;6 h MCP-1与基础相比P<0.01。1周时,而MCP-1与微栓塞前相比没有明显变化(P>0.05),心肌组织RT-PCR显示MCP-1mRNA表达只在6 h明显升高(P<0.05),1周时不再升高(P>0.05)。微栓塞1周后前壁心肌组织病理切片计数测得粒细胞为(103.0±49.4),后壁测得为(43.9±24.0),两者相比有显著差异性(P<0.05)。结论冠脉微栓塞后血清MCP-1呈现先升高后下降趋势,心肌组织MCP-1mRNA只在微栓塞后6 h升高。 Objective To investigate changes of monocyte chemotactic protein-1 ( MCP-1 ) after coronary mieroembolization (CME). Method The left anterior descending coronary artery of 12 pigs was embolized by injection of 42 m microspheres with a total of 120,000. Study was divided as acute study ( base, 2 hours and 6 hours) and chronic study ( base and 1 week). Serum MCP-1 was measured by ELISA. MCP-1mRNA from myoeardium was analyzed with RT-PCR. Leukoeytes from myocardium were counted. Results MCP-1 decreased significantly after CME (34.64 ± 2.71 pg/ml at baseline, 41.24 ± 2.88 pg/ml at 2 hours and 42.97 ± 3.54 pg/ml at 6 hours, 2 hours and 6 hours compared with base P 〈 0.05 and P 〈 0.01 respectively). At one week later, MCP-1 returned to baseline (35.33 ± 2.37 pg/ml at base and 34.92 ±3.49 pg/ml at l week). RT-PCR analysis showed that MCP-1mRNA only elevated at six hours after CME (P 〈 0.05 ). Number of leukocyte infiltration was 103.0 ± 49.4 at anterior myocardial and 43.9 ± 24.0 at posterior(P 〈 0.05). Conclusion Changes of serum MCP-1 were first decreased then returned to baseline. MCP-1 mRNA only elevates at six hours after CME.
出处 《中国分子心脏病学杂志》 CAS 2008年第3期149-152,共4页 Molecular Cardiology of China
基金 国家自然科学基金(30671998) 上海曙光追踪计划资助(06GG03)
关键词 微栓塞 冠状动脉 单核细胞趋化因子-1 Microeinbolization Coronary, artery Monocyte chemotactic protein-1
  • 相关文献

参考文献6

  • 1马剑英,钱菊英,葛均波,曾欣,黄国倩,张峰,葛雷,刘学波,张少衡,杨巍,邹云增.经导管急性冠状动脉微栓塞对急性期左心室功能的影响[J].中华超声影像学杂志,2006,15(12):948-949. 被引量:7
  • 2[2]Hurt-Camejo E,Camejo G.Potential involvement of type Ⅱ phospholipase A2 in atherosclerosis[J].Atherosclerosis,1997,132(1):1-8.
  • 3[3]Hogaboam CM,Steinhauser ML,Chenane SW,et al.Novel roles for chemokines and fibroblasts in interstitial fibrosis[J].Kidney,1998,54(6):2152-2159.
  • 4[4]Dorge H,Neumann T,Bethands M,et al.Perfusion-contraction mismatch with coronarymicrovascular obstruction:role of inflammation[J].Am J Physiol Heart Circ Physiol,2000,279(6):H2587-H2592
  • 5[5]Morimoto H,Takahashi M,lzawa A,et al.Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.Circ Res,2006 Oct 13;99(8):891-9.
  • 6[6]Frangogiannis NG,Dewald O,Xia Y,et al.Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.Circulation,2007,115:584-592.

二级参考文献3

  • 1Dorge H,Neumann T,Bethends M,et al.Perfusion-contraction mismatch with coronarymicrovascular obstruction:role of inflammation.Am J Physiol Heart Circ Physiol,2000,279:H2587-H2592.
  • 2Heusch G,Schulz R,Baumgart D,et al.Coronary microembolization.Prog Cardiovasc Dis,2001,44:217-230.
  • 3Skyschally A,Haude M,Dorge H,et al.Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization.Circulation,2004,109:2337-2342.

共引文献6

同被引文献36

  • 1中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会,杨杰孚,张健,韩雅玲.中国心力衰竭诊断和治疗指南2018[J].中华心力衰竭和心肌病杂志(中英文),2018,2(4):196-225. 被引量:823
  • 2Hori M, Inoue M. Kitakaze M.et al. Role of Adenosine in Hyperemic Response of Coronary Blood Flow in Microcirculation [J]. Am J Physiol.1986.250:509-518.
  • 3Andreas S,Rainer S, Petra G,et al. Coronary microembolization does not induce acute preconditioning against infarction in Pigs-the role of adenosine[J]. Cardiovascular Research, 2004, 63:313-322.
  • 4Hilmar D. Rainer S, Sergej B. et al. Coronary microembolization: the role of TNF-a in contractile dysfunction[J]. J Mol Cell Cardiol.2002.34 : 51- 62.
  • 5Gerd H, Rainer S, Michael H, et al. Coronary microembolization[J]. Journal of Molecular and Cellular Cardiology,2004.37:23-31.
  • 6Bujak M, Frangogiannis NG. The role of TGF-β signaling in myocardial infarction and cardiac remodeling [J].Cardiovasc Res,2007,74(2):184-195.
  • 7Border WA, Noble NA. Transforming growth factor in tissue fibrosis[J]. N Engl J Med,1994,331:1286-1292.
  • 8Li G, Borger MA, Williams WG, et al. Regional overexpres sion of insulin-like growth factor-Ⅰ and transforming growth factor-beta1 in the myocardium of patients with hypertrophic ob struetive eardiomyopathy[J]. J Thorac Cardiovasc Surg,2002 123:89-95.
  • 9Sanderson JE, I.ai KB, Shum IO, et al. Transforming growth factor-beta ( 1 ) expression in dilated cardiomyopathy [J]. Heart, 2001,86 : 701-708.
  • 10Yang Y, Zhou X, Gao H,et al. The Expression of epidermal growth factor and transforming growth factor-hetal in the stenotic tissue of congenital pelvi-ureteric junction obstruction in children[J]. J Pediatr Surg,2003. 38 : 1656-1660.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部